JP4880899B2 - 局所皮膚使用及び治療用製剤 - Google Patents
局所皮膚使用及び治療用製剤 Download PDFInfo
- Publication number
- JP4880899B2 JP4880899B2 JP2004508762A JP2004508762A JP4880899B2 JP 4880899 B2 JP4880899 B2 JP 4880899B2 JP 2004508762 A JP2004508762 A JP 2004508762A JP 2004508762 A JP2004508762 A JP 2004508762A JP 4880899 B2 JP4880899 B2 JP 4880899B2
- Authority
- JP
- Japan
- Prior art keywords
- topical formulation
- enzyme
- silicone
- topical
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
活性剤はタンパク質、特に酵素を意味するものとして理解されるべきである。
本発明によれば、製剤は、皮膚、創傷組織、及び病変組織に適用される種々の局所包帯剤に用いることができる。局所包帯剤は、活性剤が放出され、下層皮膚、創傷組織、及び病変組織に適用されることを可能にする。更に、製剤は軟膏を形成するのに用いてもよく、軟膏は、活性剤が放出され、下層皮膚、創傷組織、及び病変組織に適用されることを可能にする。
7、+99、+101、+103、+104、+107、+123、+27、+105、+109、+126、+128、+135、+156、+166、+195、+197、+204、+206、+210、+216、+217、+218、+222、+260、+265、及び/又は+274から成る群より選択される位置と同等なプロテアーゼ内の位置でアミノ酸残基を異なるアミノ酸に置換した前駆体プロテアーゼに由来する。
活性剤は種々の機能を行なうことができる。例えば、マトリックスは、壊死組織を除去し、一般的創傷清掃をするためのプロテアーゼ及び他の酵素学的創面清掃剤、血栓形成及び血栓除去酵素、自己殺菌、抗感染、及び治癒促進のためにペルオキシド、過酸、活性酸素種、及び抗接着触媒アンタゴニストを産生する薬剤、並びに皮膚治療などのための薬剤を局所的に放出することができる。
リパーゼ放出に関し、シュードモナス−メンドシナ由来リパーゼを用いて、直接上に記載された方法によりダウコーニング(登録商標)7−5300シリコーンゴム組成物を更に試験した。この実験の結果をmAbs/分の単位で以下の表2に示す。
図2Aはダウコーニング(登録商標)7−5300シリコーンゴム溶液からのプロテアーゼAの放出/送達を表し、図2Bはダウコーニング(登録商標)7−5300シリコーンゴム溶液からのリパーゼの放出/送達を表す。図は長時間にわたる2〜4%の更なる酵素のシリコーンマトリックスからの直線的放出を示している。
ることにより、酵素の放出速度を増加させる。同様に、図3Bは、種々のPVAレベルでダウコーニング(登録商標)7−5300製剤から放出したプロテアーゼAの割合を表す。グラフからわかるように、放出速度はPVA量が増加するにつれて増加している。図3Cは、種々のPVP量を有するダウコーニング(登録商標)9040/9011シリコーンマトリックスからの酵素放出を表す。図3Cにみられるように、親水性PVPをシリコーンマトリックスへ添加することにより酵素の放出速度が増加している。
Claims (56)
- 内相及び外相を含む徐放性局所用製剤であって、該内相は該外相の中に分散しており、該内相は少なくとも1つの親水性担体、少なくとも1つの親水性成分、及び活性剤としての少なくとも1つの酵素を含み;該外相は該局所用製剤からの該酵素の放出を制御するためのシリコーンマトリックスを含む、製剤。
- 該少なくとも1つの活性剤が親水性であり、該シリコーンマトリックスから放出される、請求項1に記載の局所用製剤。
- 該内相が該外相の中に分散した液滴を含み、該液滴の直径が0.1μm〜2000μmである、請求項1に記載の局所用製剤。
- 該液滴の直径が0.1μm〜1000μmである、請求項3に記載の局所用製剤。
- 該液滴の直径が0.1μm〜500μmである、請求項3に記載の局所用製剤。
- 該液滴の直径が0.1μm〜200μmである、請求項3に記載の局所用製剤。
- 該液滴の直径が0.1μm〜100μmである、請求項3に記載の局所用製剤。
- 該液滴の直径が0.1μm〜50μmである、請求項3に記載の局所用製剤。
- 該液滴の直径が0.1μm〜10μmである、請求項3に記載の局所用製剤。
- 該液滴の直径が0.1μm〜5μmである、請求項3に記載の局所用製剤。
- 該少なくとも1つの親水性担体が、ポリプロピレングリコール、ポリエチレングリコール、ポロキサマー、アルコール及び水、並びにそれらの組み合わせから選択される、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性担体がポリプロピレングリコールを含む、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性担体が局所用製剤の50重量%以下を占める、請求項1に記載の局所用製剤。
- 該少なくとも1つの酵素が、ヒドロラーゼ、クチナーゼ、オキシダーゼ、トランスフェラーゼ、レダクターゼ、ヘミセルラーゼ、エステラーゼ、イソメラーゼ、ペクチナーゼ、ラクターゼ、ペルオキシダーゼ、ラッカーゼ、カタラーゼ、及びそれらの組み合わせから選択される、請求項1に記載の局所用製剤。
- 該少なくとも1つの酵素が少なくとも1つのヒドロラーゼ酵素を含む、請求項1に記載の局所用製剤。
- 該ヒドロラーゼ酵素がリパーゼ及びプロテアーゼから選択される、請求項15に記載の局所用製剤。
- 該プロテアーゼがスブチリシンプロテアーゼを含む、請求項16に記載の局所用製剤。
- 該プロテアーゼがバシラス−レンタス由来のスブチリシン変異体又はBacillus amyloliquesfaciens由来のY217L変異体を含む、請求項16に記載の局所用製剤。
- 該ヒドロラーゼ酵素がリパーゼを含み、該リパーゼが該シリコーンマトリックスの0.0001重量%〜0.2重量%を占める、請求項15に記載の局所用製剤。
- 該ヒドロラーゼ酵素がプロテアーゼを含み、該プロテアーゼ濃度が該局所用製剤の0.1mg/g〜5.0mg/gである、請求項15に記載の局所用製剤。
- 該少なくとも1つの親水性成分がポリビニルアルコール、ポリビニルピロリドン及びそれらの組み合わせから選択される、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性成分が該内相の50重量%以下を占める、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性成分が該内相の35重量%以下を占める、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性成分が該局所用製剤の5〜40重量%を占める、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性成分が該局所用製剤の10〜35重量%を占める、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性成分が該局所用製剤の15〜35重量%を占める、請求項1に記載の局所用製剤。
- 該少なくとも1つの親水性成分が水増粘剤を含む、請求項1に記載の局所用製剤。
- 該シリコーンマトリックスが、高分子量ポリジメチルシロキサン、充填剤のないエラストマー、気泡エラストマー、シリコーンゴム、シリコーン系感圧接着剤、及びそれらの組み合わせから選択される、請求項1に記載の局所用製剤。
- 該外相がシリコーン系界面活性剤を更に含む、請求項1に記載の局所用製剤。
- パッチ包帯剤である、請求項1に記載の局所用製剤。
- 該パッチ包帯剤の厚さが25μm以下である、請求項30に記載の局所用製剤。
- 該親水性担体がプロピレングリコールであり、該酵素がプロテアーゼである、請求項30に記載の局所用製剤。
- 該親水性成分が、ポリビニルアルコール及びポリビニルプロピレンから選択される、請求項32に記載の局所用製剤。
- フィルム上の塗布剤である、請求項1に記載の局所用製剤。
- 該外相がシリコーンゴムを含む、請求項34に記載の局所用製剤。
- 軟膏である、請求項1に記載の局所用製剤。
- 該外相が少なくとも1つのシリコーンエラストマー及び少なくとも1つのシリコーン界面活性剤を含む、請求項36に記載の局所用製剤。
- 該親水性担体がプロピレングリコールである、請求項37に記載の局所用製剤。
- 該親水性成分がポリビニルアルコールである、請求項38に記載の局所用製剤。
- 少なくとも1つの親水性担体、少なくとも1つの親水性成分、及び活性剤としての少なくとも1つの酵素を含む内相をつくり;
該酵素の放出を制御するためのシリコーンマトリックスを含む外相をつくり;
該内相を該外相の中に分散させて局所用製剤を形成する、
ことを含む、徐放性局所用製剤の形成方法。 - 該分散工程が、該内相及び該外相を手でいっしょに攪拌することを含む、請求項40に記載の方法。
- 該分散工程が、高剪断ミキサーを用いて該内相及び該外相をいっしょに混合することを含む、請求項40に記載の方法。
- 該局所用製剤をパッチに成型することを更に含む、請求項40に記載の方法。
- 該分散工程が、該内相が該外相の中に分散した液滴を形成するように行われる、請求項40に記載の方法。
- 該液滴のサイズが0.1μm〜2000μmである、請求項44に記載の方法。
- 該液滴のサイズが0.1μm〜1000μmである、請求項44に記載の方法。
- 該液滴のサイズが0.1μm〜500μmである、請求項44に記載の方法。
- 該液滴のサイズが0.1μm〜200μmである、請求項44に記載の方法。
- 該液滴のサイズが0.1μm〜100μmである、請求項44に記載の方法。
- 該液滴の直径が0.1μm〜50μmである、請求項44に記載の方法。
- 該液滴の直径が0.1μm〜10μmである、請求項44に記載の方法。
- 該液滴の直径が0.1μm〜5μmである、請求項44に記載の方法。
- 該活性剤が該シリコーンマトリックスから患者の皮膚へ局所的に放出されるように、該患者の該皮膚に接触して置かれる、請求項1に記載の局所用製剤。
- 該活性剤が該シリコーンマトリックスから放出される、請求項53に記載の局所用製剤。
- 該アルコールが、多価アルコールから選択される、請求項11に記載の局所用製剤。
- 該多価アルコールが、プロピレングリコール及びグリセリンから選択される、請求項55に記載の局所用製剤。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36338602P | 2002-03-11 | 2002-03-11 | |
US60/363,386 | 2002-03-11 | ||
US43986203P | 2003-01-14 | 2003-01-14 | |
US60/439,862 | 2003-01-14 | ||
US10/385,213 | 2003-03-10 | ||
US10/385,213 US20030180281A1 (en) | 2002-03-11 | 2003-03-10 | Preparations for topical skin use and treatment |
PCT/US2003/007411 WO2003101404A2 (en) | 2002-03-11 | 2003-03-11 | Preparations for topical skin use and treatment |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005528425A JP2005528425A (ja) | 2005-09-22 |
JP2005528425A5 JP2005528425A5 (ja) | 2006-05-18 |
JP4880899B2 true JP4880899B2 (ja) | 2012-02-22 |
Family
ID=28046493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004508762A Expired - Fee Related JP4880899B2 (ja) | 2002-03-11 | 2003-03-11 | 局所皮膚使用及び治療用製剤 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030180281A1 (ja) |
EP (1) | EP1487462A4 (ja) |
JP (1) | JP4880899B2 (ja) |
KR (1) | KR20040101301A (ja) |
CN (1) | CN100496611C (ja) |
AU (1) | AU2003265225A1 (ja) |
CA (1) | CA2478871C (ja) |
WO (1) | WO2003101404A2 (ja) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
US7223386B2 (en) * | 2002-03-11 | 2007-05-29 | Dow Corning Corporation | Preparations for topical skin use and treatment |
US20060083776A1 (en) * | 2003-10-27 | 2006-04-20 | Bott Richard R | Preparations for topical application and methods of delivering an active agent to a substrate |
ATE424816T1 (de) * | 2003-10-27 | 2009-03-15 | Dow Corning | Zubereitungen für die topische anwendung und verfahren zur abgabe eines wirkstoffs an ein substrat |
US20070218115A1 (en) * | 2003-10-27 | 2007-09-20 | Bott Richard R | Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate |
WO2005092300A1 (en) * | 2004-03-12 | 2005-10-06 | Dow Corning Corporation | Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs using a silicone polyether |
JP2008531582A (ja) | 2005-02-24 | 2008-08-14 | ディフュージョン・ファーマシューティカルズ・エルエルシー | トランスカロテノイド、それらの合成、配合、および使用 |
WO2006138035A1 (en) * | 2005-06-13 | 2006-12-28 | Dow Corning Corporation | Vehicle for the delivery of topical lipid soluble pharmaceutical agents |
KR101460980B1 (ko) * | 2006-05-23 | 2014-11-13 | 다우 코닝 코포레이션 | 활성제를 전달하기 위한 신규한 실리콘막 형성제 |
US7842848B2 (en) | 2006-11-13 | 2010-11-30 | Ossur Hf | Absorbent structure in an absorbent article |
WO2008109887A1 (en) * | 2007-03-08 | 2008-09-12 | Biozone Laboratories Inc. | Dressing formulations to prevent and reduce scarring |
HU227970B1 (en) * | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
JP2009273674A (ja) * | 2008-05-15 | 2009-11-26 | Alcare Co Ltd | 皮膚用シリコーン系粘着剤、皮膚用シリコーン系貼付材及びその製造方法 |
KR100979347B1 (ko) * | 2009-03-25 | 2010-08-31 | 삼일제약주식회사 | 항진균 조성물 |
CA2765697C (en) | 2009-06-22 | 2019-11-12 | Diffusion Pharmaceuticals Llc | Diffusion enhancing compounds and their use alone or with thrombolytics |
BR112012013812A2 (pt) | 2009-12-08 | 2018-05-29 | Healthpoint Ltd | "composições para desbridamento enzimático de feridas com atividade enzimática melhorada" |
EP2575487B1 (en) | 2010-06-02 | 2017-10-18 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
IN2013CN00460A (ja) | 2010-06-22 | 2015-07-03 | Novozymes As | |
CN103153279B (zh) | 2010-08-31 | 2016-10-12 | 奥利沃实验室有限责任公司 | 皮肤组合物及其使用方法 |
AU2012312170C1 (en) | 2011-09-21 | 2018-01-04 | Shiseido Company, Ltd. | Compositions and methods for treating conditions of compromised skin barrier function |
US10045965B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
CA2916183C (en) | 2013-07-03 | 2022-03-29 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with electronic component |
WO2015177204A1 (en) | 2014-05-20 | 2015-11-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system containing rotigotine |
CA2948221C (en) | 2014-05-20 | 2022-11-22 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
EP3145503A1 (en) | 2014-05-20 | 2017-03-29 | LTS Lohmann Therapie-Systeme AG | Method for adjusting the release of active agent in a transdermal delivery system |
CA2997220A1 (en) * | 2015-09-03 | 2017-03-09 | Delivra Inc. | Transdermal formulations for delivery of doxycycline, and their use in the treatment of doxycycline-responsive diseases and conditions |
US20190046481A1 (en) * | 2015-09-18 | 2019-02-14 | Delivra Inc. | Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions |
CA3002455C (en) | 2015-11-09 | 2024-02-13 | Shiseido Americas Corporation | Compositions and methods for application over skin |
KR20230014850A (ko) | 2016-03-24 | 2023-01-30 | 디퓨젼 파마슈티컬즈 엘엘씨 | 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도 |
GB201616223D0 (en) * | 2016-09-23 | 2016-11-09 | University College Cardiff Consultants Limited | Topical treatment patch |
CN107096037B (zh) * | 2017-04-11 | 2019-12-31 | 同济大学 | 一种酶促小分子自组装制备纳米凝胶的方法 |
US11739194B2 (en) | 2017-11-23 | 2023-08-29 | Danmarks Tekniske Universitet | Glycerol-silicone elastomers as active matrices with controllable release profiles |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2736721A (en) | 1952-10-08 | 1956-02-28 | Optionally | |
US2814601A (en) * | 1954-04-29 | 1957-11-26 | Dow Corning | Organopolysiloxane adhesive and pressure-sensitive adhesive tape containing same |
DE1017883B (de) * | 1954-07-08 | 1957-10-17 | Fellows Gear Shaper Co | Schalt- und Vorschubeinrichtung fuer Zahnradherstellungsmaschinen |
US3528940A (en) * | 1966-12-15 | 1970-09-15 | Gen Electric | Silicone pressure-sensitive adhesive of improved strength |
GB1372034A (en) | 1970-12-31 | 1974-10-30 | Unilever Ltd | Detergent compositions |
BE788554A (fr) * | 1971-09-23 | 1973-01-02 | Rech Applic Scient Sogeras S A | Procede pour la fabrication de substances actives pulverisees protegeescontre un milieu biologique |
US4053580A (en) * | 1975-01-01 | 1977-10-11 | G. D. Searle & Co. | Microsealed pharmaceutical delivery device |
US3972328A (en) * | 1975-07-28 | 1976-08-03 | E. R. Squibb & Sons, Inc. | Surgical bandage |
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4760025A (en) * | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
US5801038A (en) * | 1984-05-29 | 1998-09-01 | Genencor International Inc. | Modified subtilisins having amino acid alterations |
US5972682A (en) * | 1984-05-29 | 1999-10-26 | Genencor International, Inc. | Enzymatically active modified subtilisins |
EP0218272B1 (en) * | 1985-08-09 | 1992-03-18 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
US5389536A (en) * | 1986-11-19 | 1995-02-14 | Genencor, Inc. | Lipase from Pseudomonas mendocina having cutinase activity |
FR2618337B1 (fr) * | 1987-07-22 | 1989-12-15 | Dow Corning Sa | Pansement chirurgical et procede pour le fabriquer |
FR2653438B1 (fr) * | 1989-10-23 | 1993-06-11 | Dow Corning Sa | Composition de silicone expansible et son utilisation. |
US5145937A (en) * | 1989-11-09 | 1992-09-08 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Polyimides with carbonyl and ether connecting groups between the aromatic rings |
CA2046802C (en) * | 1990-08-15 | 2007-05-22 | Donald Zane Fortney | Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
FR2673948B1 (fr) | 1991-03-13 | 1995-03-10 | Dow Corning Sa | Compositions de silicone expansibles utiles a la realisation de pansements medicaux. |
US5232702A (en) * | 1991-07-22 | 1993-08-03 | Dow Corning Corporation | Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices |
US5547681A (en) * | 1994-07-14 | 1996-08-20 | Union Carbide Chemicals & Plastics Technology Corporation | Dermal patch |
FR2725366B1 (fr) * | 1994-10-10 | 1996-11-22 | Oreal | Composition cosmetique comprenant des huiles siliconees |
US6060546A (en) * | 1996-09-05 | 2000-05-09 | General Electric Company | Non-aqueous silicone emulsions |
WO1998022084A1 (en) * | 1996-11-19 | 1998-05-28 | The Procter & Gamble Company | Skin care compositions |
AR015977A1 (es) * | 1997-10-23 | 2001-05-30 | Genencor Int | Variantes de proteasa multiplemente substituida con carga neta alterada para su empleo en detergentes |
FR2780645B1 (fr) * | 1998-07-06 | 2000-08-11 | Oreal | Produit pour application topique contenant une lipase, un precurseur de vitamine et un alcool gras |
FR2783713B1 (fr) * | 1998-09-29 | 2002-05-31 | Oreal | Utilisation d'une gomme de silicone pour stabiliser l'acide ascorbique et nouvelles compositions contenant ces composants |
US6207717B1 (en) * | 1999-01-12 | 2001-03-27 | Dow Corning Corporation | Entrapment of vitamins with an elastomeric silicone polyether |
US6337086B1 (en) * | 1999-02-06 | 2002-01-08 | Dow Corning Corporation | Pressure sensitive adhesive compositions for transdermal drug delivery devices |
US6200581B1 (en) * | 1999-04-28 | 2001-03-13 | Dow Corning Corporation | Elastomeric silicone terpolymer |
US6168782B1 (en) * | 1999-05-24 | 2001-01-02 | Dow Corning Corporation | Elastomeric silicone containing an active ingredient |
US6238657B1 (en) * | 1999-07-12 | 2001-05-29 | Dow Corning Corporation | Oil-in-oil and three-phase emulsions |
US6080394A (en) * | 1999-11-08 | 2000-06-27 | Dow Corning Corporation | Polar solvent-in-oil emulsions and multiple emulsions |
-
2003
- 2003-03-10 US US10/385,213 patent/US20030180281A1/en not_active Abandoned
- 2003-03-11 JP JP2004508762A patent/JP4880899B2/ja not_active Expired - Fee Related
- 2003-03-11 CN CNB038089572A patent/CN100496611C/zh not_active Expired - Fee Related
- 2003-03-11 EP EP03756147A patent/EP1487462A4/en not_active Withdrawn
- 2003-03-11 WO PCT/US2003/007411 patent/WO2003101404A2/en active Application Filing
- 2003-03-11 CA CA2478871A patent/CA2478871C/en not_active Expired - Fee Related
- 2003-03-11 KR KR10-2004-7014277A patent/KR20040101301A/ko not_active Application Discontinuation
- 2003-03-11 AU AU2003265225A patent/AU2003265225A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN100496611C (zh) | 2009-06-10 |
KR20040101301A (ko) | 2004-12-02 |
WO2003101404A3 (en) | 2004-07-15 |
CA2478871C (en) | 2012-05-01 |
JP2005528425A (ja) | 2005-09-22 |
AU2003265225A8 (en) | 2003-12-19 |
CA2478871A1 (en) | 2003-12-11 |
CN1646145A (zh) | 2005-07-27 |
WO2003101404A2 (en) | 2003-12-11 |
EP1487462A2 (en) | 2004-12-22 |
US20030180281A1 (en) | 2003-09-25 |
AU2003265225A1 (en) | 2003-12-19 |
EP1487462A4 (en) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4880899B2 (ja) | 局所皮膚使用及び治療用製剤 | |
JP2005528425A5 (ja) | ||
US20070190152A1 (en) | Method for providing an active agent topically to the skin | |
JP4745976B2 (ja) | 局所適用のための調製物及び活性剤の基体への送達方法 | |
US20060083776A1 (en) | Preparations for topical application and methods of delivering an active agent to a substrate | |
US5750134A (en) | Bioadhesive composition and patch | |
US5750136A (en) | Bioadhesive composition and patch | |
EP0498841B1 (en) | Bioadhesive composition and patch | |
KR20000076053A (ko) | 박리성 필름을 사용한 효소의 국소적 적용 | |
US20070218115A1 (en) | Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060313 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060313 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20060314 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091030 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100128 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100204 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100301 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100308 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100330 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100331 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110728 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110915 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111116 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111202 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4880899 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141209 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |